Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders' Equity

v3.20.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at the beginning at Jun. 30, 2019 $ 16,594 $ 1 $ 127,327 $ (108,870) $ (1,864)
Balance at the beginning (In shares) at Jun. 30, 2019   856,765      
Common stock sold for cash, net of offering costs of $240 1,720   1,720    
Common stock sold for cash, net of offering costs of $240, Shares   186,666      
Issuance of pre-funded warrants, net of transaction costs of $240 50   50    
Share-based compensation 55   55    
Forfeiture of share-based payments     (61) 61  
Foreign currency translation loss (Gain) (304)       (304)
Net loss (1,147)     (1,147)  
Balance at end at Sep. 30, 2019 16,968 $ 1 129,091 (109,956) (2,168)
Balance at end (In shares) at Sep. 30, 2019   1,043,431      
Balance at the beginning at Jun. 30, 2020 10,238 $ 1 128,826 (116,636) (1,953)
Balance at the beginning (In shares) at Jun. 30, 2020   1,108,374      
Share-based compensation 38   38    
Forfeiture of share-based payments     (14) 14  
Foreign currency translation loss (Gain) 178       178
Net loss (2,718)     (2,718)  
Balance at end at Sep. 30, 2020 $ 7,736 $ 1 $ 128,850 $ (119,340) $ (1,775)
Balance at end (In shares) at Sep. 30, 2020   1,108,374